In 2007, Bangladesh’s national strategy to reduce anemia included adolescents and newly married women as target groups for iron and folic acid (IFA) supplementation. This thesis is comprised of a pilot study and a double-blinded randomized controlled trial (RCT) aimed at providing evidence-based research to inform decision-making on periconceptional IFA programs in rural Bangladesh. Results from the pilot study indicate that women who marry during adolescence had significantly longer intervals to first pregnancy compared to adult brides; however, the time interval was not long enough to delay family formation beyond adolescence. Education, age at marriage and contraceptive use were significant factors for delaying time to first pregnancy. The RCT examined the effect of daily periconceptional iron (60 mg) and folic acid (400 μg) vs. folic acid (FA) on iron and folate indictors. Of 272 women, 37% were anemic (Hb <120 g/L), 13% had low plasma folate levels (≤10 nmol), 15% were iron deficient (plasma ferritin <12 μg/L or TfR>4.4 mg/L), 11% were iron deficient and anemic and 81% were estimated to have <500 mg of iron stores. Adolescents had significantly lower plasma ferritin and body iron stores vs. adults. Among 88 pregnant women (PW), an interaction between treatment and adherence was significantly associated with change in Hb (p=0.04) and anemia (p=0.05). During pregnancy, group differences for iron status were not significant. Among NPW (n=146), IFA reduced anemia by 80.0% (95% CI: 0.04, 1.00, p=0.05) and significantly improved change in plasma ferritin concentrations by level of adherence in a dose-response relationship (p=0.01). In both groups, mean plasma folate concentrations increased from 16.9 to31.8 nmol/L and the prevalence of low plasma folate concentrations (<10 nmol/L) was reduced from 14% to 8%. Results suggest that periconceptional iron supplementation along with adequate folic acid intake is efficacious in reducing the prevalence of anemia during pregnancy and improving body iron stores before pregnancy when adherence is high. The effectiveness of periconceptional IFA supplementation remains unclear. Further research needs to examine maternal and infant functional and health outcomes, ways to increase adherence and cost-effectiveness.

In 2007, Bangladesh’s national strategy to reduce anemia included adolescents and newly married women as target groups for iron and folic acid (IFA) supplementation. This thesis is comprised of a pilot study and a double-blinded randomized controlled trial (RCT) aimed at providing evidence-based research to inform decision-making on periconceptional IFA programs in rural Bangladesh. Results from the pilot study indicate that women who marry during adolescence had significantly longer intervals to first pregnancy compared to adult brides; however, the time interval was not long enough to delay family formation beyond adolescence. Education, age at marriage and contraceptive use were significant factors for delaying time to first pregnancy. The RCT examined the effect of daily periconceptional iron (60 mg) and folic acid (400 μg) vs. folic acid (FA) on iron and folate indictors. Of 272 women, 37% were anemic (Hb <120 g/L), 13% had low plasma folate levels (≤10 nmol), 15% were iron deficient (plasma ferritin <12 μg/L or TfR>4.4 mg/L), 11% were iron deficient and anemic and 81% were estimated to have <500 mg of iron stores. Adolescents had significantly lower plasma ferritin and body iron stores vs. adults. Among 88 pregnant women (PW), an interaction between treatment and adherence was significantly associated with change in Hb (p=0.04) and anemia (p=0.05). During pregnancy, group differences for iron status were not significant. Among NPW (n=146), IFA reduced anemia by 80.0% (95% CI: 0.04, 1.00, p=0.05) and significantly improved change in plasma ferritin concentrations by level of adherence in a dose-response relationship (p=0.01). In both groups, mean plasma folate concentrations increased from 16.9 to31.8 nmol/L and the prevalence of low plasma folate concentrations (<10 nmol/L) was reduced from 14% to 8%. Results suggest that periconceptional iron supplementation along with adequate folic acid intake is efficacious in reducing the prevalence of anemia during pregnancy and improving body iron stores before pregnancy when adherence is high. The effectiveness of periconceptional IFA supplementation remains unclear. Further research needs to examine maternal and infant functional and health outcomes, ways to increase adherence and cost-effectiveness.

Title page, table of contents and abstract only. The complete thesis in print form is available from the University of Adelaide Library. / A range of epidemiological, clinical and experimental studies have demonstrated that exposure of an embryo to a suboptimal environment in vivo or ex vivo during early embryo development is associated with altered development of cardiovascular, neuroendocrine and metabolic disorders in adult life. A number of perturbations during early embryo development result in developmental adaptations by the embryo to ensure immediate survival, whilst programming the embryo for altered fetal and placental development, resulting in the eventual onset of adult disease. It has been previously shown that maternal nutrient restriction during the periconceptional period results in a hyperactivation of the pituitary - adrenal axis and increased mean arterial blood pressure in twin but not singleton pregnancies. It was therefore the first aim of this thesis to interrogate the impact of maternal undernutrition during the periconceptional period (defined as from at least 45 days prior until 7 days after conception) on fetal and placental development during early pregnancy at - day 55 of pregnancy, which coincides with the period of maximal placental growth. In Chapter 2, it has been demonstrated that there are important relationships between maternal weight gain during the periconceptional period and feto-placental growth during the first - 55 days of pregnancy and that periconceptional undernutrition has a differential effect on these relationships in singleton and twin pregnancies. In singleton pregnancies, periconceptional undernutrition disrupts the relationship between maternal weight gain during the periconceptional period and utero-placental growth and in twin pregnancies, periconceptional undernutrition results in the emergence of an inverse relationship between maternal weight gain during early pregnancy and uteroplacental growth and in a dependence of fetal growth on placental growth. (Chapter 2) In order to investigate the origins of the physiological adaptations that lead to the development of hyperactivation of the pituitary - adrenal axis and increased mean arterial blood pressure in late gestational fetuses after exposure as an embryo to periconceptional undernutrition, we investigated the development and steroidogenic capacity of the fetal adrenal gland and development of the fetal heart and kidney at - 55 days gestation (Chapter 3 and 4). The relative weight of the fetal adrenal and adrenal IGF-1, IGF-1 R, IGF-2, IGF-2R and CYP 17 mRNA expression were lower in twin compared to singleton fetuses. There was evidence that in control singletons, IGF-2R expression plays an important role in the regulation of adrenal growth and CYP 17 mRNA expression during early pregnancy. In control twins, however, whilst there was a significant positive relationship between adrenal CYP 17 and IGF-2 mRNA expression, adrenal weight was directly related to the level of adrenal IGF-1 mRNA expression. There was no effect of periconceptional undernutrition on the level of expression of any of the placental or adrenal genes in the study. In PCUN ewes, carrying singletons, however, there was a loss of the relationships between either adrenal IGF-2, IGF-2R and IGF-1 mRNA expression and adrenal growth and CYP 17 expression which were present in control singletons. Similarly in ewes carrying twins, maternal undernutrition during the periconceptional period resulted in the loss of the relationships between adrenal growth and IGF-1 expression and between _ adrenal CYP 17 and IGF-2 expression which were present in control twin fetuses. Whilst there was no effect of fetal number on fetal heart growth at - d55 in twin fetuses, there was a direct relationship between relative fetal heart and adrenal weights, which was present in both the PCUN and control groups. There was also a significant inverse relationship between maternal weight at conception and relative fetal heart weight in PCUN twin, but not PCUN singleton or control fetuses (Chapter 3). In control pregnancies maternal weight gain during the periconceptional period is inversely related to the relative weight of the fetal kidney at -55d pregnancy. In this group, relative kidney weight was also directly related to renal IGF-1 mRNA expression. In control twins maternal weight gain was inversely related to fetal kidney weight and this effect was ablated when the effects of maternal cortisol was controlled for in the analysis. In the PCUN group, whilst there was an inverse relationship between maternal weight gain during the periconceptional period and relative kidney weight, it was not possible to separate the independent effects of maternal weight loss during the periconceptional period and the subsequent weight gain during the period of refeeding. Renal IGF-1 mRNA expression was higher and renal lGF-1 R and 2R expression were lower in twin fetuses compared to singletons. After exposure to PCUN, renal IGF-1 expression was also higher than in control pregnancies independent of the fetal number (Chapter 4). Superovulation, artificial insemination, embryo transfer and in vitro embryo culture are used in a range of assisted reproductive technologies, and it has been demonstrated that varying the composition of the culture media can result in a change in pre and postnatal development. Culture of sheep embryos in media containing serum is associated with fetal overgrowth which is phenotypic of the Large Offspring Syndrome. It is not known how the combination of superovulation, artificial insemination and embryo transfer alone impacts fetoplacental development in late gestation of the sheep. There have been no studies, however, examining the differential impact of superovulation, artificial insemination and embryo transfer with or without in vitro embryo culture in the absence or presence of human serum on feto-placental development in Singleton and twin pregnancies (Chapter 5). I have therefore tested the hypothesis that superovulation, artificial insemination and embryo transfer with or without in vitro embryo culture in the presence or absence of human serum differentially alters the growth of the placenta, fetus and fetal organs during late gestation when compared to naturally conceived controls and that these effects are different in singleton and twin pregnancies. The fetal weight, CRL and abdominal circumference were significantly larger in IVCHS singleton fetuses. A novel finding in this study was lower fetal weights of twin fetuses in the ET and IVCNS groups compared to NM control twin fetuses. In addition, placental weights were lighter in twin fetuses in the ET, IVCNS and IVCHS treatment groups and this is partially due to a failure to initiate compensatory growth of placentomes in twin pregnancies (Chapter 5). The results of this thesis therefore highlight the complex interactions between the periconceptional environment (in vivo or ex vivo) and embryo or fetal number on the programming fetal and placental development. Maternal undernutrition during the periconceptional period and superovulation, artificial insemination and embryo transfer with or without in vitro culture in the absence or presence of serum alters fetal development, and I have demonstrated that these changes in fetal growth can be explained by changes in placental growth trajectory. Furthermore, a novel finding of this study is that perturbations of the periconceptional environment affect feto-placental development differently in singleton and twin pregnancies. / Thesis (Ph.D.) -- University of Adelaide, School of Molecular and Biomedical Science, 2006

Title page, table of contents and abstract only. The complete thesis in print form is available from the University of Adelaide Library. / A range of epidemiological, clinical and experimental studies have demonstrated that exposure of an embryo to a suboptimal environment in vivo or ex vivo during early embryo development is associated with altered development of cardiovascular, neuroendocrine and metabolic disorders in adult life. A number of perturbations during early embryo development result in developmental adaptations by the embryo to ensure immediate survival, whilst programming the embryo for altered fetal and placental development, resulting in the eventual onset of adult disease. It has been previously shown that maternal nutrient restriction during the periconceptional period results in a hyperactivation of the pituitary - adrenal axis and increased mean arterial blood pressure in twin but not singleton pregnancies. It was therefore the first aim of this thesis to interrogate the impact of maternal undernutrition during the periconceptional period (defined as from at least 45 days prior until 7 days after conception) on fetal and placental development during early pregnancy at - day 55 of pregnancy, which coincides with the period of maximal placental growth. In Chapter 2, it has been demonstrated that there are important relationships between maternal weight gain during the periconceptional period and feto-placental growth during the first - 55 days of pregnancy and that periconceptional undernutrition has a differential effect on these relationships in singleton and twin pregnancies. In singleton pregnancies, periconceptional undernutrition disrupts the relationship between maternal weight gain during the periconceptional period and utero-placental growth and in twin pregnancies, periconceptional undernutrition results in the emergence of an inverse relationship between maternal weight gain during early pregnancy and uteroplacental growth and in a dependence of fetal growth on placental growth. (Chapter 2) In order to investigate the origins of the physiological adaptations that lead to the development of hyperactivation of the pituitary - adrenal axis and increased mean arterial blood pressure in late gestational fetuses after exposure as an embryo to periconceptional undernutrition, we investigated the development and steroidogenic capacity of the fetal adrenal gland and development of the fetal heart and kidney at - 55 days gestation (Chapter 3 and 4). The relative weight of the fetal adrenal and adrenal IGF-1, IGF-1 R, IGF-2, IGF-2R and CYP 17 mRNA expression were lower in twin compared to singleton fetuses. There was evidence that in control singletons, IGF-2R expression plays an important role in the regulation of adrenal growth and CYP 17 mRNA expression during early pregnancy. In control twins, however, whilst there was a significant positive relationship between adrenal CYP 17 and IGF-2 mRNA expression, adrenal weight was directly related to the level of adrenal IGF-1 mRNA expression. There was no effect of periconceptional undernutrition on the level of expression of any of the placental or adrenal genes in the study. In PCUN ewes, carrying singletons, however, there was a loss of the relationships between either adrenal IGF-2, IGF-2R and IGF-1 mRNA expression and adrenal growth and CYP 17 expression which were present in control singletons. Similarly in ewes carrying twins, maternal undernutrition during the periconceptional period resulted in the loss of the relationships between adrenal growth and IGF-1 expression and between _ adrenal CYP 17 and IGF-2 expression which were present in control twin fetuses. Whilst there was no effect of fetal number on fetal heart growth at - d55 in twin fetuses, there was a direct relationship between relative fetal heart and adrenal weights, which was present in both the PCUN and control groups. There was also a significant inverse relationship between maternal weight at conception and relative fetal heart weight in PCUN twin, but not PCUN singleton or control fetuses (Chapter 3). In control pregnancies maternal weight gain during the periconceptional period is inversely related to the relative weight of the fetal kidney at -55d pregnancy. In this group, relative kidney weight was also directly related to renal IGF-1 mRNA expression. In control twins maternal weight gain was inversely related to fetal kidney weight and this effect was ablated when the effects of maternal cortisol was controlled for in the analysis. In the PCUN group, whilst there was an inverse relationship between maternal weight gain during the periconceptional period and relative kidney weight, it was not possible to separate the independent effects of maternal weight loss during the periconceptional period and the subsequent weight gain during the period of refeeding. Renal IGF-1 mRNA expression was higher and renal lGF-1 R and 2R expression were lower in twin fetuses compared to singletons. After exposure to PCUN, renal IGF-1 expression was also higher than in control pregnancies independent of the fetal number (Chapter 4). Superovulation, artificial insemination, embryo transfer and in vitro embryo culture are used in a range of assisted reproductive technologies, and it has been demonstrated that varying the composition of the culture media can result in a change in pre and postnatal development. Culture of sheep embryos in media containing serum is associated with fetal overgrowth which is phenotypic of the Large Offspring Syndrome. It is not known how the combination of superovulation, artificial insemination and embryo transfer alone impacts fetoplacental development in late gestation of the sheep. There have been no studies, however, examining the differential impact of superovulation, artificial insemination and embryo transfer with or without in vitro embryo culture in the absence or presence of human serum on feto-placental development in Singleton and twin pregnancies (Chapter 5). I have therefore tested the hypothesis that superovulation, artificial insemination and embryo transfer with or without in vitro embryo culture in the presence or absence of human serum differentially alters the growth of the placenta, fetus and fetal organs during late gestation when compared to naturally conceived controls and that these effects are different in singleton and twin pregnancies. The fetal weight, CRL and abdominal circumference were significantly larger in IVCHS singleton fetuses. A novel finding in this study was lower fetal weights of twin fetuses in the ET and IVCNS groups compared to NM control twin fetuses. In addition, placental weights were lighter in twin fetuses in the ET, IVCNS and IVCHS treatment groups and this is partially due to a failure to initiate compensatory growth of placentomes in twin pregnancies (Chapter 5). The results of this thesis therefore highlight the complex interactions between the periconceptional environment (in vivo or ex vivo) and embryo or fetal number on the programming fetal and placental development. Maternal undernutrition during the periconceptional period and superovulation, artificial insemination and embryo transfer with or without in vitro culture in the absence or presence of serum alters fetal development, and I have demonstrated that these changes in fetal growth can be explained by changes in placental growth trajectory. Furthermore, a novel finding of this study is that perturbations of the periconceptional environment affect feto-placental development differently in singleton and twin pregnancies. / Thesis (Ph.D.) -- University of Adelaide, School of Molecular and Biomedical Science, 2006

The prepartum surge in fetal plasma cortisol, essential for the maturation of organs in mammals and the normal timing of parturition in some species, including sheep, may result from an increase in the molar ratio of adrenocorticotropin (ACTH) to pro-opiomelanocortin (POMC) in the fetal circulation. Related to this, the cleavage of POMC to ACTH by the enzyme, prohormone convertase 1 (PC1), may be influenced by corticotrophin releasing hormone (CRH) stimulation. Accumulating evidence suggests that the capacity of individual corticotrophs to process POMC to ACTH may vary and individual corticotrophs are differentially responsive to CRH. It is not known, however, if there are separate corticotroph subpopulations in the fetal sheep pituitary which can be identified by differential colocalisation of POMC, ACTH and the CRH receptor 1, CRHR₁, nor if changes in the relative proportions of such subpopulations play a role in the molecular mechanisms underlying the overall changes in pituitary function described previously during gestation and in response to suboptimal uterine environments. To investigate these hypotheses, it was first necessary to develop novel methods for the simultaneous immunohistochemical labelling of POMC, ACTH and CRHR₁ in individual cells on sections of fetal sheep pituitary. In addition, I developed and validated an automated method to categorise and count individual cells to increase the quantitative power of this study. Pituitary tissue was collected from control fetuses at 53-55 (n=6), 63-85 (n=6), 110 (n=4), 139-141 (n=4) and 144-145 (n=6) days gestation. Two animal models, known to alter pituitary function in the fetal sheep, were used to investigate corticotrophic adaptations to suboptimal uterine environments. For the maternal periconceptional undernutrition (PCUN) model, maternal feed was reduced to 70% of maintenance requirements from at least 45 days before to 7 days after mating and fetal tissues were collected at 53-55 days gestation (n=7). For the placental restriction (PR) model, the majority of the placental attachment sites were removed in five ewes before mating and fetal tissues were collected at 140 (n=4) and 144 (n=4) days gestation. Pituitary sections were simultaneously labelled with antisera raised against full length POMC, ACTH and CRHR₁ and the proportions of pituitary cells with combinations of antisera were quantified. Four subpopulations of corticotrophs were identified, which expressed either: POMC+ACTH+CRHR₁, ACTH+CRHR₁, POMC+ CRHR₁ or POMConly. There was a significant decrease in the proportion of pituitary cells expressing POMC+ACTH+CRHR₁ between 53-55 and 65-85 days gestation, before an increase at 110 days gestation and a further marked decrease between 139-141 and 144-145 days gestation. In fetuses from the PCUN group, the proportion of pituitary cells expressing POMC+ACTH+CRHR₁ in early gestation was reduced. PR resulted in a significantly higher proportion of corticotrophs expressing POMC+ACTH+CRHR₁ during the prepartum period. This work represents the discovery of the differential expression of POMC, ACTH and CRHR₁ in individual corticotrophs of the fetal sheep pituitary and the first insights into the pituitary adaptations to periconceptional nutrient restriction and placental restriction at the level of individual corticotrophs. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1337370 / Thesis (Ph.D.) -- University of Adelaide, School of Molecular and Biomedical Science, 2008

The prepartum surge in fetal plasma cortisol, essential for the maturation of organs in mammals and the normal timing of parturition in some species, including sheep, may result from an increase in the molar ratio of adrenocorticotropin (ACTH) to pro-opiomelanocortin (POMC) in the fetal circulation. Related to this, the cleavage of POMC to ACTH by the enzyme, prohormone convertase 1 (PC1), may be influenced by corticotrophin releasing hormone (CRH) stimulation. Accumulating evidence suggests that the capacity of individual corticotrophs to process POMC to ACTH may vary and individual corticotrophs are differentially responsive to CRH. It is not known, however, if there are separate corticotroph subpopulations in the fetal sheep pituitary which can be identified by differential colocalisation of POMC, ACTH and the CRH receptor 1, CRHR₁, nor if changes in the relative proportions of such subpopulations play a role in the molecular mechanisms underlying the overall changes in pituitary function described previously during gestation and in response to suboptimal uterine environments. To investigate these hypotheses, it was first necessary to develop novel methods for the simultaneous immunohistochemical labelling of POMC, ACTH and CRHR₁ in individual cells on sections of fetal sheep pituitary. In addition, I developed and validated an automated method to categorise and count individual cells to increase the quantitative power of this study. Pituitary tissue was collected from control fetuses at 53-55 (n=6), 63-85 (n=6), 110 (n=4), 139-141 (n=4) and 144-145 (n=6) days gestation. Two animal models, known to alter pituitary function in the fetal sheep, were used to investigate corticotrophic adaptations to suboptimal uterine environments. For the maternal periconceptional undernutrition (PCUN) model, maternal feed was reduced to 70% of maintenance requirements from at least 45 days before to 7 days after mating and fetal tissues were collected at 53-55 days gestation (n=7). For the placental restriction (PR) model, the majority of the placental attachment sites were removed in five ewes before mating and fetal tissues were collected at 140 (n=4) and 144 (n=4) days gestation. Pituitary sections were simultaneously labelled with antisera raised against full length POMC, ACTH and CRHR₁ and the proportions of pituitary cells with combinations of antisera were quantified. Four subpopulations of corticotrophs were identified, which expressed either: POMC+ACTH+CRHR₁, ACTH+CRHR₁, POMC+ CRHR₁ or POMConly. There was a significant decrease in the proportion of pituitary cells expressing POMC+ACTH+CRHR₁ between 53-55 and 65-85 days gestation, before an increase at 110 days gestation and a further marked decrease between 139-141 and 144-145 days gestation. In fetuses from the PCUN group, the proportion of pituitary cells expressing POMC+ACTH+CRHR₁ in early gestation was reduced. PR resulted in a significantly higher proportion of corticotrophs expressing POMC+ACTH+CRHR₁ during the prepartum period. This work represents the discovery of the differential expression of POMC, ACTH and CRHR₁ in individual corticotrophs of the fetal sheep pituitary and the first insights into the pituitary adaptations to periconceptional nutrient restriction and placental restriction at the level of individual corticotrophs. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1337370 / Thesis (Ph.D.) -- University of Adelaide, School of Molecular and Biomedical Science, 2008

The prepartum surge in fetal plasma cortisol, essential for the maturation of organs in mammals and the normal timing of parturition in some species, including sheep, may result from an increase in the molar ratio of adrenocorticotropin (ACTH) to pro-opiomelanocortin (POMC) in the fetal circulation. Related to this, the cleavage of POMC to ACTH by the enzyme, prohormone convertase 1 (PC1), may be influenced by corticotrophin releasing hormone (CRH) stimulation. Accumulating evidence suggests that the capacity of individual corticotrophs to process POMC to ACTH may vary and individual corticotrophs are differentially responsive to CRH. It is not known, however, if there are separate corticotroph subpopulations in the fetal sheep pituitary which can be identified by differential colocalisation of POMC, ACTH and the CRH receptor 1, CRHR₁, nor if changes in the relative proportions of such subpopulations play a role in the molecular mechanisms underlying the overall changes in pituitary function described previously during gestation and in response to suboptimal uterine environments. To investigate these hypotheses, it was first necessary to develop novel methods for the simultaneous immunohistochemical labelling of POMC, ACTH and CRHR₁ in individual cells on sections of fetal sheep pituitary. In addition, I developed and validated an automated method to categorise and count individual cells to increase the quantitative power of this study. Pituitary tissue was collected from control fetuses at 53-55 (n=6), 63-85 (n=6), 110 (n=4), 139-141 (n=4) and 144-145 (n=6) days gestation. Two animal models, known to alter pituitary function in the fetal sheep, were used to investigate corticotrophic adaptations to suboptimal uterine environments. For the maternal periconceptional undernutrition (PCUN) model, maternal feed was reduced to 70% of maintenance requirements from at least 45 days before to 7 days after mating and fetal tissues were collected at 53-55 days gestation (n=7). For the placental restriction (PR) model, the majority of the placental attachment sites were removed in five ewes before mating and fetal tissues were collected at 140 (n=4) and 144 (n=4) days gestation. Pituitary sections were simultaneously labelled with antisera raised against full length POMC, ACTH and CRHR₁ and the proportions of pituitary cells with combinations of antisera were quantified. Four subpopulations of corticotrophs were identified, which expressed either: POMC+ACTH+CRHR₁, ACTH+CRHR₁, POMC+ CRHR₁ or POMConly. There was a significant decrease in the proportion of pituitary cells expressing POMC+ACTH+CRHR₁ between 53-55 and 65-85 days gestation, before an increase at 110 days gestation and a further marked decrease between 139-141 and 144-145 days gestation. In fetuses from the PCUN group, the proportion of pituitary cells expressing POMC+ACTH+CRHR₁ in early gestation was reduced. PR resulted in a significantly higher proportion of corticotrophs expressing POMC+ACTH+CRHR₁ during the prepartum period. This work represents the discovery of the differential expression of POMC, ACTH and CRHR₁ in individual corticotrophs of the fetal sheep pituitary and the first insights into the pituitary adaptations to periconceptional nutrient restriction and placental restriction at the level of individual corticotrophs. / http://proxy.library.adelaide.edu.au/login?url= http://library.adelaide.edu.au/cgi-bin/Pwebrecon.cgi?BBID=1337370 / Thesis (Ph.D.) -- University of Adelaide, School of Molecular and Biomedical Science, 2008

Made available in DSpace on 2016-03-22T17:27:38Z (GMT). No. of bitstreams: 1 cintia.pdf: 399237 bytes, checksum: 411794e4a2f292dd1123c42f8b410d51 (MD5) Previous issue date: 2006-11-20 / To determine folic acid use and associated factors, a cross-sectional population-based study was carried out in the five maternities from Pelotas - RS, Brazil. Data were collected from April 1st to August 15th, 2006. 1450 women were interviewed. A standard questionnaire was applied in the hospitals. Statistical analysis was done by Poisson Regression. Prevalence of folic acid consumption during pregnancy was 31.8% and periconceptional use was 4.3%. The following characteristics were associated to folic acid use: white skin color, schooling above 9 years, family income higher than 600 reais, age groups older than 30, planned pregnancies, seven or more prenatal care visits, knowledge about folic acid and prenatal care realization in the private health system. It is important to promote folic acid use among fertile age women and to supply with folic acid poorer women in order to prevent neural tube defects / Com o objetivo de determinar a prevalência do uso do ácido fólico e fatores associados, realizou-se um estudo transversal de base populacional nas cinco maternidades da cidade de Pelotas - RS, Brasil. A coleta de dados ocorreu no período de 1° de abril a 15 de agosto de 2006 com 1.450 mulheres. As entrevistas foram realizadas em nível hospitalar por questionário padronizado. A análise estatística se realizou por regressão de Poisson. A prevalência do uso de ácido fólico na gestação foi de 31,8%, e no período periconcepcional, foi de 4,3%. Os fatores associados ao uso de ácido fólico foram: cor branca, escolaridade acima de nove anos, renda acima de 600 reais, idade acima de 30 anos, gestação planejada, sete ou mais consultas de pré-natal, consultas na rede privada de saúde e conhecimento sobre o ácido fólico. Para diminuir a prevalência de defeitos do tubo neural é importante promoverse o uso do ácido fólico nas mulheres em idade fértil, nas mulheres socioeconomicamente menos favorecidas e disponibilizá-lo na rede pública de saúde.

Objetivo: Verificar se há diferença entre o consumo habitual de folato entre mães de crianças com Síndrome de Down e mães de crianças sem malformações. Métodos: Foi realizado um estudo de caso-controle, com um total de 100 mães das quais 50, incluídas no grupo caso, apresentavam filhos com Síndrome de Down e 50, consideradas grupo controle,tinham filhos sem malformações congênitas. Aplicou-se um questionário de consumo habitual de alimentos contendo questões relativas à classificação sócio-econômica e ao consumo de alimentos-fonte e alimentos fortificados com esta vitamina. Todas participantes assinaram o Termo de Consentimento Livre e Esclarecido. Resultados: Entre as variáveis analisadas, somente a quantidade de ácido fólico consumida habitualmente e a idade no momento do nascimento do filho, diferiram-se significantemente entre os grupos. Mães caso consumiram em média 359,1 μg/dia (dp ± 91,9) de folato, enquanto as mães do grupo controle, 425,5 μg/dia (dp± 104,3), (p=0,001). A idade que tiveram seus filhos foi no grupo caso 27, 5 anos (dp± 4,8) de e no grupo controle de 25,4 (dp ±5,3), (p=0,042). Somente 3,4% das entrevistadas relataram uso de ácido fólico ou polivitamínicos de forma periconcepcional ou em algum momento da gestação. Conclusões: Embora pelo presente estudo tenha havido diferença significativa entre o consumo de folato no grupo caso e no controle é importante que não se descarte possíveis fatores bioquímicos envolvidos e aqui não avaliados. / Objective: Check if exists difference between the usual consumption of folate in mothers of children with Down Syndrome and in mothers of children without congenital abnormalities. Methods: A case-control study was accomplished, with a sample of 100 mothers from which, 50 had children with Down Syndrome and 50, considered group control, children without congenital abnormalities. A questionnaire of quantitative frequency was applied containing questions related to the socioeconomic class and the food-source consumption, and foods fortified with folic acid. All participants signed the Informed Consent Form. Results: Among the variables in analysis, only the daily amount of folic acid consumed and the age that the mothers had their babies were significant different between the two groups. Mothers of children with Down Syndrome consumed 359,1 μg/day (dp ± 91,9) of folate, while the mothers of control group consumed, 425,5 μg/day (dp± 104,3), (p=0,001). The age that they had their babies were in group case 27, 5 years (dp± 4,8) and in the control group, 25,4 (dp ±5,3), (p=0,042). Only 3,4% of the interviewee related use of folic acid or others vitamines before or during the pregnancy. Conclusion: Although in the present study has been a significant difference between the consumption of folate in the case group and in the control, is important not to discard possible biochemical factors involved and here not evaluated.

Objetivo: Verificar se há diferença entre o consumo habitual de folato entre mães de crianças com Síndrome de Down e mães de crianças sem malformações. Métodos: Foi realizado um estudo de caso-controle, com um total de 100 mães das quais 50, incluídas no grupo caso, apresentavam filhos com Síndrome de Down e 50, consideradas grupo controle,tinham filhos sem malformações congênitas. Aplicou-se um questionário de consumo habitual de alimentos contendo questões relativas à classificação sócio-econômica e ao consumo de alimentos-fonte e alimentos fortificados com esta vitamina. Todas participantes assinaram o Termo de Consentimento Livre e Esclarecido. Resultados: Entre as variáveis analisadas, somente a quantidade de ácido fólico consumida habitualmente e a idade no momento do nascimento do filho, diferiram-se significantemente entre os grupos. Mães caso consumiram em média 359,1 μg/dia (dp ± 91,9) de folato, enquanto as mães do grupo controle, 425,5 μg/dia (dp± 104,3), (p=0,001). A idade que tiveram seus filhos foi no grupo caso 27, 5 anos (dp± 4,8) de e no grupo controle de 25,4 (dp ±5,3), (p=0,042). Somente 3,4% das entrevistadas relataram uso de ácido fólico ou polivitamínicos de forma periconcepcional ou em algum momento da gestação. Conclusões: Embora pelo presente estudo tenha havido diferença significativa entre o consumo de folato no grupo caso e no controle é importante que não se descarte possíveis fatores bioquímicos envolvidos e aqui não avaliados. / Objective: Check if exists difference between the usual consumption of folate in mothers of children with Down Syndrome and in mothers of children without congenital abnormalities. Methods: A case-control study was accomplished, with a sample of 100 mothers from which, 50 had children with Down Syndrome and 50, considered group control, children without congenital abnormalities. A questionnaire of quantitative frequency was applied containing questions related to the socioeconomic class and the food-source consumption, and foods fortified with folic acid. All participants signed the Informed Consent Form. Results: Among the variables in analysis, only the daily amount of folic acid consumed and the age that the mothers had their babies were significant different between the two groups. Mothers of children with Down Syndrome consumed 359,1 μg/day (dp ± 91,9) of folate, while the mothers of control group consumed, 425,5 μg/day (dp± 104,3), (p=0,001). The age that they had their babies were in group case 27, 5 years (dp± 4,8) and in the control group, 25,4 (dp ±5,3), (p=0,042). Only 3,4% of the interviewee related use of folic acid or others vitamines before or during the pregnancy. Conclusion: Although in the present study has been a significant difference between the consumption of folate in the case group and in the control, is important not to discard possible biochemical factors involved and here not evaluated.